This company has been acquired
Enfusion (ENFN) Resumen de Acciones
Enfusion, Inc. ofrece soluciones de software como servicio para el sector de la gestión de inversiones en Estados Unidos, Europa, Oriente Medio, África y Asia-Pacífico. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 2/6 |
| Crecimiento futuro | 5/6 |
| Rendimiento pasado | 2/6 |
| Salud financiera | 6/6 |
| Dividendos | 0/6 |
Recompensas
Análisis de riesgos
ENFN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de Enfusion, Inc.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$10.76 |
| Máximo en las últimas 52 semanas | US$11.80 |
| Mínimo de 52 semanas | US$7.83 |
| Beta | 0.93 |
| Cambio en 1 mes | -3.06% |
| Variación en 3 meses | -3.15% |
| Cambio de 1 año | 15.08% |
| Variación en 3 años | -12.66% |
| Variación en 5 años | n/a |
| Variación desde la OPV | -45.68% |
Noticias y actualizaciones recientes
Recent updates
An Update On The Enfusion Buyout
Summary Clearwater Analytics' $1.5 billion acquisition of Enfusion is a strategic move to expand its portfolio management offerings and enhance its SaaS revenue growth. Enfusion's strong business model and larger margin of safety made it a better investment compared to other fintech buyout deals. The deal is already priced in, offering limited upside for new investors, but promises long-term growth and potential synergies for existing shareholders. Clearwater's financing plan involves a mix of loans, revolving credit, and stock, with expectations of 20% revenue growth and improved EBITDA. Read the full article on Seeking AlphaEnfusion: Revenue Growth Should Start To Accelerate
Summary I maintain a buy rating for ENFN, anticipating revenue growth to exceed 20% due to improving macro conditions and solid execution. The macro environment has shown signs of turnaround, with rate cuts and reduced election uncertainty, boosting demand sentiment. ENFN's strong execution is evident in stable front book revenue growth, customer additions, and successful upmarket penetration. Read the full article on Seeking AlphaIs There An Opportunity With Enfusion, Inc.'s (NYSE:ENFN) 32% Undervaluation?
Key Insights Enfusion's estimated fair value is US$15.33 based on 2 Stage Free Cash Flow to Equity Current share price...Why Private Equity Will Buyout Enfusion
Summary Enfusion's steady revenue growth and low net profit margins make it an attractive buyout target for private equity firms, with a potential buyout price of $10-$15 per share. Despite using outdated tech buzzwords, Enfusion's sophisticated trading terms and cloud-native platform cater to institutional investors' needs for connectivity, data, and APIs. Major shareholders FTV and Malherbe control over 50% of Enfusion's stock, potentially commanding a significant buyout premium or blocking deals. Investors should add Enfusion to their watchlist, considering a small position post-U.S. election, as the company is profitable with growing top-line revenue. Read the full article on Seeking Alpha
Critical Expansion And Diverse Client Base Propel Future Growth And Margin Enhancement
Enfusion's diversification into insurance and banking and its focus on economical front-to-back platform solutions aim to stabilize and grow revenue.Enfusion: Growth Should Accelerate In Coming Quarters
Summary ENFN's Q2 2024 earnings show growth in revenue and margins, with potential for growth acceleration in the future. ENFN is successfully penetrating new markets and upmarket, despite challenges in the macro environment. The key to ENFN's positive rerating lies in reaccelerating growth and improving profitability. Read the full article on Seeking AlphaInvestors Can Find Comfort In Enfusion's (NYSE:ENFN) Earnings Quality
Enfusion, Inc.'s ( NYSE:ENFN ) earnings announcement last week didn't impress shareholders. While the headline numbers...Enfusion: Expectations Of Faster Growth And Higher Margins Justify A Buy Rating
Summary Enfusion targets to grow its top line at a faster pace by optimizing its customer mix. Positive operating leverage and an increase in operating efficiency will support higher EBITDA margins for Enfusion. I expect ENFN to achieve revenue growth acceleration and profitability improvement in the future, and this supports a Buy rating. Read the full article on Seeking AlphaIs Now An Opportune Moment To Examine Enfusion, Inc. (NYSE:ENFN)?
Enfusion, Inc. ( NYSE:ENFN ), is not the largest company out there, but it saw a significant share price rise of 20% in...Capital Allocation Trends At Enfusion (NYSE:ENFN) Aren't Ideal
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Enfusion: Product Is Sticky And Industry Is Huge
Summary I am recommending a buy rating as I see room for ENFN to grow and visible catalysts for growth acceleration. The company provides an end-to-end SaaS solution for investment managers, making it a sticky product with high pricing power. The industry is large and healthy, with ample opportunities for Enfusion to expand its market share. Read the full article on Seeking AlphaCalculating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Enfusion fair value estimate is US$10.34 With US$9.21 share...Investors Appear Satisfied With Enfusion, Inc.'s (NYSE:ENFN) Prospects As Shares Rocket 28%
Enfusion, Inc. ( NYSE:ENFN ) shareholders would be excited to see that the share price has had a great month, posting a...Enfusion: Still Bullish Considering Q3 EBITDA Beat
Summary Enfusion's EBITDA expanded by +48% YoY in Q3 2023, which was +6% better than what the market had expected. ENFN's long-term prospects are favorable, taking into account the room for revenue growth and profit margin improvement. I retain a Buy rating for ENFN stock, in consideration of its good recent quarterly results and positive financial outlook. Read the full article on Seeking AlphaWhy Enfusion, Inc. (NYSE:ENFN) Could Be Worth Watching
Enfusion, Inc. ( NYSE:ENFN ), is not the largest company out there, but it received a lot of attention from a...Enfusion Faces Cross-Currents In Investment Management Software Market
Summary Enfusion reported Q2 2023 financial results below expectations. The company provides investment management software-as-a-service to global investment managers. The global investment management software market is expected to grow at a CAGR of 10.2% from 2019 to 2025. ENFN faces a variety of pressures from institutional prospects, so I remain Neutral [Hold] on the stock in the near term. Read the full article on Seeking AlphaEnfusion, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
Enfusion, Inc. ( NYSE:ENFN ) just released its latest second-quarter report and things are not looking great. Results...Enfusion: Multiple Catalysts
Summary Enfusion, Inc. could reverse its earlier share price underperformance, when interest rates peak and the new management team proves itself in time to come. Enfusion's long-term growth potential is decent, and the company has a good chance of delivering positive surprises with its actual top line performance for the remaining quarters of 2023. I award a Buy rating to Enfusion, as I have identified multiple potential catalysts for the stock. Read the full article on Seeking AlphaEnfusion, Inc.'s (NYSE:ENFN) Intrinsic Value Is Potentially 32% Above Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Enfusion fair value estimate is US$14.93 Current share price...Rentabilidad de los accionistas
| ENFN | US Software | Mercado US | |
|---|---|---|---|
| 7D | -1.5% | -1.9% | 1.7% |
| 1Y | 15.1% | -18.3% | 25.1% |
Rentabilidad vs. Industria: ENFN superó a la industria US Software, que obtuvo un rendimiento del -18.3% el año pasado.
Rentabilidad vs. Mercado: ENFN superó al mercado US, que obtuvo un rendimiento del 25.1% el año pasado.
Volatilidad de los precios
| ENFN volatility | |
|---|---|
| ENFN Average Weekly Movement | 2.4% |
| Software Industry Average Movement | 10.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Precio estable de las acciones: ENFN no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado US.
Volatilidad a lo largo del tiempo: La volatilidad semanal de ENFN (2%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1997 | 1,143 | Oleg Movchan | www.enfusion.com |
Enfusion, Inc. ofrece soluciones de software como servicio para el sector de la gestión de inversiones en Estados Unidos, Europa, Oriente Medio, África y Asia-Pacífico. La empresa ofrece Portfolio Management System, que genera un libro de registro de inversiones en tiempo real que consta de herramientas de valoración y riesgo, lo que permite a los usuarios analizar datos de cartera agregados o descompuestos para directores de inversiones (CIO) y gestores de carteras; y Order and Execution Management System, que permite a gestores de carteras, operadores, equipos de cumplimiento y analistas comunicar electrónicamente órdenes de operaciones para una variedad de clases de activos, gestionar órdenes de operaciones y aplicar sistémicamente normativas de negociación y directrices internas. También ofrece el sistema de contabilidad/contabilidad general, un libro mayor propio que automatiza la contabilización de los asientos del libro mayor para todas las transacciones de efectivo y valores para directores financieros, directores de operaciones, contables y equipos de operaciones; el sistema Enfusion Analytics, que permite a los directores financieros, gestores de carteras, operadores y analistas analizar carteras a través de horizontes temporales y automatizar informes visualizados personalizados para las partes interesadas internas y externas; y servicios gestionados y basados en tecnología.
Resumen de fundamentos de Enfusion, Inc.
| Estadísticas fundamentales de ENFN | |
|---|---|
| Capitalización bursátil | US$1.39b |
| Beneficios(TTM) | US$2.82m |
| Ingresos (TTM) | US$201.61m |
¿Está ENFN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ENFN | |
|---|---|
| Ingresos | US$201.61m |
| Coste de los ingresos | US$64.87m |
| Beneficio bruto | US$136.74m |
| Otros gastos | US$133.91m |
| Beneficios | US$2.82m |
Últimos beneficios comunicados
Dec 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.03 |
| Margen bruto | 67.82% |
| Margen de beneficio neto | 1.40% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado ENFN a largo plazo?
Ver rendimiento histórico y comparativaAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2025/04/22 02:02 |
| Precio de las acciones al final del día | 2025/04/17 00:00 |
| Beneficios | 2024/12/31 |
| Ingresos anuales | 2024/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Enfusion, Inc. está cubierta por 1 analistas. 5 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Gabriela Borges | Goldman Sachs |